BioCentury
ARTICLE | Distillery Therapeutics

The mitochondrial peptidase NLN identified as AML target

May 29, 2020 9:36 PM UTC

INDICATION: Acute myelogenous leukemia (AML)...

BCIQ Company Profiles

University of Toronto